2024
Practice Update Commentary on: Beta-Hydroxybutyrate Levels and Risk of Diabetic Ketoacidosis in Adults with Type 1 Diabetes Treated with Sotagliflozin
Peter PR. Available at: https://www.practiceupdate.com/content/beta-hydroxybutyrate-levels-and-the-risk-of-diabetic-ketoacidosis-in-adults-with-type-1-diabetes-treated-with-sotagliflozin/170808/65/8/1. Accessed October 18, 2024Commentaries, Editorials and LettersUse of Sodium-Glucose Cotransporter Inhibitors in Type 1 Diabetes: The Promise and the Perils.
Peter PR, Inzucchi SE. Use of Sodium-Glucose Cotransporter Inhibitors in Type 1 Diabetes: The Promise and the Perils. Endocr Pract 2024 PMID: 38548175, DOI: 10.1016/j.eprac.2024.03.022.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus Statements
2023
Tailoring the Treatment of Type 2 Diabetes Mellitus to Patients with Cardiovascular Disease
Peter PR, Inzucchi SI. Tailoring the Treatment of Type 2 Diabetes Mellitus to Patients with Cardiovascular Disease. In: 3rd Edition of Diabetes and Cardiovascular Disease. ed. M. Johnstone and A. Veves. Humana Press 2023; 1043-70.ChaptersPractice Update Commentary on: Recovery from diabetes mellitus in primary aldosteronism patients after adrenalectomy
Peter, P. Practice Update Commentary on: Recovery from diabetes mellitus in primary aldosteronism patients after adrenalectomy. https://www.practiceupdate.com/content/recovery-from-diabetes-in-patients-with-primary-aldosteronism-after-adrenalectomy/146966/65/8/1Commentaries, Editorials and LettersPractice Update: A commentary on: SGLT2i and GLP-1 RA therapy in type 1 diabetes and reno-vascular outcomes: a real-world study
Peter, P. Practice Update: A commentary on: SGLT2i and GLP-1 RA therapy in type 1 diabetes and reno-vascular outcomes: a real-world study Available at: https://www.practiceupdate.com/content/glucose-lowering-therapies-for-type-1-diabetes-and-renovascular-outcomes/156565/65/8/1.Commentaries, Editorials and Letters
2020
Adjuvant external beam radiotherapy for surgically resected, nonmetastatic anaplastic thyroid cancer
Saeed NA, Kelly JR, Deshpande HA, Bhatia AK, Burtness BA, Judson BL, Mehra S, Edwards HA, Yarbrough WG, Peter PR, Holt EH, Decker RH, Husain ZA, Park HS. Adjuvant external beam radiotherapy for surgically resected, nonmetastatic anaplastic thyroid cancer. Head & Neck 2020, 42: 1031-1044. PMID: 32011055, DOI: 10.1002/hed.26086.Peer-Reviewed Original ResearchConceptsAnaplastic thyroid cancerLonger OSAdjuvant EBRTThyroid cancerAdjuvant external beam radiotherapyNational Cancer DatabaseExternal beam radiotherapyConcurrent chemoradiationConcurrent chemotherapyImproved survivalMedian ageCancer DatabaseRetrospective analysisBeam radiotherapyEBRTChemotherapyPatientsCancerUVAChemoradiationResectionRadiotherapy
2019
Compromised endothelial function in transgender men taking testosterone
Gulanski BI, Flannery CA, Peter PR, Leone CA, Stachenfeld NS. Compromised endothelial function in transgender men taking testosterone. Clinical Endocrinology 2019, 92: 138-144. PMID: 31765022, PMCID: PMC6957681, DOI: 10.1111/cen.14132.Peer-Reviewed Original ResearchConceptsEndothelial functionTransgender menEndothelial dysfunctionCisgender femalesClinical cardiovascular riskCardiovascular risk factorsImpaired endothelial functionEarly follicular phaseAndrogen excessCardiovascular riskVasodilatory responseCoronary arteryHormonal milieuFollicular phaseTestosterone treatmentMenstrual cycleRisk factorsFemale genderAtherosclerotic plaquesEarly signsTestosteroneTotal TSImportant markerDysfunctionMenPersonalized Management of Type 2 Diabetes
Peter PR, Lupsa BC. Personalized Management of Type 2 Diabetes. Current Diabetes Reports 2019, 19: 115. PMID: 31686226, DOI: 10.1007/s11892-019-1244-0.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsType 2 diabetesManagement of patientsUnique patient characteristicsSpecific patient subpopulationsClass of agentsGlycemic targetsTreatment landscapeMedical therapyPatient characteristicsPharmacotherapeutic optionsPatient subpopulationsIndividualized carePersonalized managementClinical practiceType 2ReviewOur goalRecent FindingsWePatientsDiabetesTherapyManagementPhysiciansCare
2016
The rising cost of diabetes care in the USA
Peter P, Lipska K. The rising cost of diabetes care in the USA. The Lancet Diabetes & Endocrinology 2016, 4: 479-480. PMID: 27156052, PMCID: PMC5380140, DOI: 10.1016/s2213-8587(15)00519-7.Commentaries, Editorials and LettersContinuous glucose monitoring in the hospital
Peter, P.R., Inzucchi, S.E. Continuous glucose monitoring in the hospital. In: Managing diabetes and hyperglycemia in the hospital setting. American Diabetes Association 2016; 323-335Chapters
2015
An unusual case of rickets and how whole exome sequencing helped to correct a diagnosis
Peter PR, Brownstein CA, Yao GQ, Olear EA, Simpson CA, Agrawal PB, Carpenter TO, Insogna KL. An unusual case of rickets and how whole exome sequencing helped to correct a diagnosis. AACE Clinical Case Rep 2:e278-e283, 2016Peer-Reviewed Case Reports and Technical Notes
2014
Diet quality is associated with circulating C-reactive protein but not irisin levels in humans.
Park KH, Zaichenko L, Peter P, Davis CR, Crowell JA, Mantzoros CS. Diet quality is associated with circulating C-reactive protein but not irisin levels in humans. Metabolism: Clinical And Experimental 2014, 63: 233-41. PMID: 24315778, PMCID: PMC4373656, DOI: 10.1016/j.metabol.2013.10.011.Peer-Reviewed Original ResearchCirculating irisin levels are not affected by coffee intake: a randomized controlled trial.
Peter PR, Park KH, Huh JY, Wedick NM, Mantzoros CS. Circulating irisin levels are not affected by coffee intake: a randomized controlled trial. PloS One 2014, 9: e94463. PMID: 24728416, PMCID: PMC3984159, DOI: 10.1371/journal.pone.0094463.Peer-Reviewed Original Research
2011
Risk of Poor Outcomes with Novel and Traditional Biomarkers at Clinical AKI Diagnosis
Hall IE, Coca SG, Perazella MA, Eko UU, Luciano RL, Peter PR, Han WK, Parikh CR. Risk of Poor Outcomes with Novel and Traditional Biomarkers at Clinical AKI Diagnosis. Clinical Journal Of The American Society Of Nephrology 2011, 6: 2740-2749. PMID: 22034509, PMCID: PMC3255362, DOI: 10.2215/cjn.04960511.Peer-Reviewed Original ResearchConceptsKidney injury molecule-1Neutrophil gelatinase-associated lipocalinAcute kidney injuryAcute tubular necrosisMicroscopy scorePrimary outcomeIL-18Prognostic utilityClinical assessmentInjury molecule-1Peak serum creatinineProspective cohort studyGelatinase-associated lipocalinFirst dayUrine protein biomarkersProtein biomarker concentrationsAKI criteriaAKI diagnosisAKI stageBaseline GFRHospital deathKidney injuryCohort studySerum creatinineTubular necrosis
2008
Cardiac arrhythmias after subarachnoid hemorrhage: risk factors and impact on outcome.
Frontera JA, Parra A, Shimbo D, Fernandez A, Schmidt JM, Peter P, Claassen J, Wartenberg KE, Rincon F, Badjatia N, Naidech A, Connolly ES, Mayer SA. Cardiac arrhythmias after subarachnoid hemorrhage: risk factors and impact on outcome. Cerebrovascular Diseases (Basel, Switzerland) 2008, 26: 71-8. PMID: 18525201, PMCID: PMC2909703, DOI: 10.1159/000135711.Peer-Reviewed Original Research